Melatonin alleviates sepsis-induced acute lung injury by inhibiting necroptosis via reducing circulating mtDNA release
Background Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality in critically ill patients. Melatonin (Mel) has shown significant protective effects against sepsis-induced ALI, but its precise m...
Saved in:
| Published in: | Molecular medicine (Cambridge, Mass.) Vol. 31; no. 1; pp. 176 - 15 |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
BioMed Central
07.05.2025
BMC |
| Subjects: | |
| ISSN: | 1528-3658, 1076-1551, 1528-3658 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Background
Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality in critically ill patients. Melatonin (Mel) has shown significant protective effects against sepsis-induced ALI, but its precise mechanism remains unclear.
Methods
A cecal ligation and puncture (CLP) model was used to induce sepsis in male C57BL/6 mice, which were divided into four groups: Control, Sham, CLP, and CLP + Mel. ALI severity was evaluated via hematoxylin and eosin (H&E) staining, lung wet/dry ratio, and serum biomarkers (SP-D, sRAGE). Inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured in serum and bronchoalveolar lavage fluid using ELISA. Circulating mitochondrial DNA (mtDNA) subtypes (D-loop, mt-CO1, mMito) were quantified by real-time PCR. TUNEL staining was performed to assess lung cell apoptosis. Necroptosis and STING pathway activation were analyzed via Western blot and immunofluorescence.
Results
Sepsis led to increased circulating mtDNA levels and activation of necroptosis signaling pathways. Melatonin treatment alleviated sepsis-induced ALI, improving survival, reducing inflammatory cytokines and mtDNA release, and suppressing necroptosis. Intraperitoneal injection of mtDNA in mice activated necroptosis, while RIP1 inhibitor Nec-1 counteracted mtDNA-induced lung damage and necroptosis in sepsis-induced ALI. Additionally, melatonin significantly inhibited STING pathway activation. Further experiments revealed that STING modulation influenced necroptosis protein expression and mediated melatonin’s protective effects in sepsis-induced ALI.
Conclusion
Melatonin mitigates sepsis-induced ALI by suppressing necroptosis through inhibition of STING activation and reduction of mtDNA release. These findings suggest melatonin as a potential therapeutic strategy for sepsis-induced ALI. |
|---|---|
| AbstractList | Background
Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality in critically ill patients. Melatonin (Mel) has shown significant protective effects against sepsis-induced ALI, but its precise mechanism remains unclear.
Methods
A cecal ligation and puncture (CLP) model was used to induce sepsis in male C57BL/6 mice, which were divided into four groups: Control, Sham, CLP, and CLP + Mel. ALI severity was evaluated via hematoxylin and eosin (H&E) staining, lung wet/dry ratio, and serum biomarkers (SP-D, sRAGE). Inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured in serum and bronchoalveolar lavage fluid using ELISA. Circulating mitochondrial DNA (mtDNA) subtypes (D-loop, mt-CO1, mMito) were quantified by real-time PCR. TUNEL staining was performed to assess lung cell apoptosis. Necroptosis and STING pathway activation were analyzed via Western blot and immunofluorescence.
Results
Sepsis led to increased circulating mtDNA levels and activation of necroptosis signaling pathways. Melatonin treatment alleviated sepsis-induced ALI, improving survival, reducing inflammatory cytokines and mtDNA release, and suppressing necroptosis. Intraperitoneal injection of mtDNA in mice activated necroptosis, while RIP1 inhibitor Nec-1 counteracted mtDNA-induced lung damage and necroptosis in sepsis-induced ALI. Additionally, melatonin significantly inhibited STING pathway activation. Further experiments revealed that STING modulation influenced necroptosis protein expression and mediated melatonin’s protective effects in sepsis-induced ALI.
Conclusion
Melatonin mitigates sepsis-induced ALI by suppressing necroptosis through inhibition of STING activation and reduction of mtDNA release. These findings suggest melatonin as a potential therapeutic strategy for sepsis-induced ALI. Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality in critically ill patients. Melatonin (Mel) has shown significant protective effects against sepsis-induced ALI, but its precise mechanism remains unclear. A cecal ligation and puncture (CLP) model was used to induce sepsis in male C57BL/6 mice, which were divided into four groups: Control, Sham, CLP, and CLP + Mel. ALI severity was evaluated via hematoxylin and eosin (H&E) staining, lung wet/dry ratio, and serum biomarkers (SP-D, sRAGE). Inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured in serum and bronchoalveolar lavage fluid using ELISA. Circulating mitochondrial DNA (mtDNA) subtypes (D-loop, mt-CO1, mMito) were quantified by real-time PCR. TUNEL staining was performed to assess lung cell apoptosis. Necroptosis and STING pathway activation were analyzed via Western blot and immunofluorescence. Sepsis led to increased circulating mtDNA levels and activation of necroptosis signaling pathways. Melatonin treatment alleviated sepsis-induced ALI, improving survival, reducing inflammatory cytokines and mtDNA release, and suppressing necroptosis. Intraperitoneal injection of mtDNA in mice activated necroptosis, while RIP1 inhibitor Nec-1 counteracted mtDNA-induced lung damage and necroptosis in sepsis-induced ALI. Additionally, melatonin significantly inhibited STING pathway activation. Further experiments revealed that STING modulation influenced necroptosis protein expression and mediated melatonin's protective effects in sepsis-induced ALI. Melatonin mitigates sepsis-induced ALI by suppressing necroptosis through inhibition of STING activation and reduction of mtDNA release. These findings suggest melatonin as a potential therapeutic strategy for sepsis-induced ALI. Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality in critically ill patients. Melatonin (Mel) has shown significant protective effects against sepsis-induced ALI, but its precise mechanism remains unclear.BACKGROUNDSepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality in critically ill patients. Melatonin (Mel) has shown significant protective effects against sepsis-induced ALI, but its precise mechanism remains unclear.A cecal ligation and puncture (CLP) model was used to induce sepsis in male C57BL/6 mice, which were divided into four groups: Control, Sham, CLP, and CLP + Mel. ALI severity was evaluated via hematoxylin and eosin (H&E) staining, lung wet/dry ratio, and serum biomarkers (SP-D, sRAGE). Inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured in serum and bronchoalveolar lavage fluid using ELISA. Circulating mitochondrial DNA (mtDNA) subtypes (D-loop, mt-CO1, mMito) were quantified by real-time PCR. TUNEL staining was performed to assess lung cell apoptosis. Necroptosis and STING pathway activation were analyzed via Western blot and immunofluorescence.METHODSA cecal ligation and puncture (CLP) model was used to induce sepsis in male C57BL/6 mice, which were divided into four groups: Control, Sham, CLP, and CLP + Mel. ALI severity was evaluated via hematoxylin and eosin (H&E) staining, lung wet/dry ratio, and serum biomarkers (SP-D, sRAGE). Inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured in serum and bronchoalveolar lavage fluid using ELISA. Circulating mitochondrial DNA (mtDNA) subtypes (D-loop, mt-CO1, mMito) were quantified by real-time PCR. TUNEL staining was performed to assess lung cell apoptosis. Necroptosis and STING pathway activation were analyzed via Western blot and immunofluorescence.Sepsis led to increased circulating mtDNA levels and activation of necroptosis signaling pathways. Melatonin treatment alleviated sepsis-induced ALI, improving survival, reducing inflammatory cytokines and mtDNA release, and suppressing necroptosis. Intraperitoneal injection of mtDNA in mice activated necroptosis, while RIP1 inhibitor Nec-1 counteracted mtDNA-induced lung damage and necroptosis in sepsis-induced ALI. Additionally, melatonin significantly inhibited STING pathway activation. Further experiments revealed that STING modulation influenced necroptosis protein expression and mediated melatonin's protective effects in sepsis-induced ALI.RESULTSSepsis led to increased circulating mtDNA levels and activation of necroptosis signaling pathways. Melatonin treatment alleviated sepsis-induced ALI, improving survival, reducing inflammatory cytokines and mtDNA release, and suppressing necroptosis. Intraperitoneal injection of mtDNA in mice activated necroptosis, while RIP1 inhibitor Nec-1 counteracted mtDNA-induced lung damage and necroptosis in sepsis-induced ALI. Additionally, melatonin significantly inhibited STING pathway activation. Further experiments revealed that STING modulation influenced necroptosis protein expression and mediated melatonin's protective effects in sepsis-induced ALI.Melatonin mitigates sepsis-induced ALI by suppressing necroptosis through inhibition of STING activation and reduction of mtDNA release. These findings suggest melatonin as a potential therapeutic strategy for sepsis-induced ALI.CONCLUSIONMelatonin mitigates sepsis-induced ALI by suppressing necroptosis through inhibition of STING activation and reduction of mtDNA release. These findings suggest melatonin as a potential therapeutic strategy for sepsis-induced ALI. Abstract Background Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality in critically ill patients. Melatonin (Mel) has shown significant protective effects against sepsis-induced ALI, but its precise mechanism remains unclear. Methods A cecal ligation and puncture (CLP) model was used to induce sepsis in male C57BL/6 mice, which were divided into four groups: Control, Sham, CLP, and CLP + Mel. ALI severity was evaluated via hematoxylin and eosin (H&E) staining, lung wet/dry ratio, and serum biomarkers (SP-D, sRAGE). Inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured in serum and bronchoalveolar lavage fluid using ELISA. Circulating mitochondrial DNA (mtDNA) subtypes (D-loop, mt-CO1, mMito) were quantified by real-time PCR. TUNEL staining was performed to assess lung cell apoptosis. Necroptosis and STING pathway activation were analyzed via Western blot and immunofluorescence. Results Sepsis led to increased circulating mtDNA levels and activation of necroptosis signaling pathways. Melatonin treatment alleviated sepsis-induced ALI, improving survival, reducing inflammatory cytokines and mtDNA release, and suppressing necroptosis. Intraperitoneal injection of mtDNA in mice activated necroptosis, while RIP1 inhibitor Nec-1 counteracted mtDNA-induced lung damage and necroptosis in sepsis-induced ALI. Additionally, melatonin significantly inhibited STING pathway activation. Further experiments revealed that STING modulation influenced necroptosis protein expression and mediated melatonin’s protective effects in sepsis-induced ALI. Conclusion Melatonin mitigates sepsis-induced ALI by suppressing necroptosis through inhibition of STING activation and reduction of mtDNA release. These findings suggest melatonin as a potential therapeutic strategy for sepsis-induced ALI. |
| ArticleNumber | 176 |
| Author | Wei, Xuebiao Wang, Zhonghua Xu, Jia Su, Zedazhong Peng, Yuce Luo, Minghao Wei, Lingyu Luo, Suxin Chen, Shenglong |
| Author_xml | – sequence: 1 givenname: Yuce surname: Peng fullname: Peng, Yuce organization: Department of Cardiology, the First Affiliated Hospital of Chongqing Medical University – sequence: 2 givenname: Jia surname: Xu fullname: Xu, Jia organization: Department of emergency, The first affiliated hospital of Sun Yat-sen University – sequence: 3 givenname: Lingyu surname: Wei fullname: Wei, Lingyu organization: Department of emergency, The first affiliated hospital of Sun Yat-sen University – sequence: 4 givenname: Minghao surname: Luo fullname: Luo, Minghao organization: Department of Cardiology, the First Affiliated Hospital of Chongqing Medical University – sequence: 5 givenname: Shenglong surname: Chen fullname: Chen, Shenglong organization: Department of Critical Care Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University – sequence: 6 givenname: Xuebiao surname: Wei fullname: Wei, Xuebiao organization: Department of Geriatric Intensive Medicine, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University – sequence: 7 givenname: Suxin surname: Luo fullname: Luo, Suxin organization: Department of Cardiology, the First Affiliated Hospital of Chongqing Medical University – sequence: 8 givenname: Zedazhong surname: Su fullname: Su, Zedazhong email: 673946537@qq.com organization: Department of Geriatric Cardiology, The First Affiliated Hospital of Kunming Medical University, Department of Cardiology, Guangdong Provincial People’s Hospital, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Southern Medical University, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University – sequence: 9 givenname: Zhonghua surname: Wang fullname: Wang, Zhonghua email: 340609319@qq.com organization: Department of Geriatrics, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangdong Provincial Geriatrics Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40335920$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstuFDEQRS0URB7wAyxQL9k0lO12P1YoSnhECrCBtWW7qyceeezBdo80-Xo86QQlLLLyleveU1JVnZIjHzwS8pbCB0r79mOiAAxqYKIGylhf374gJ1QUwVvRHz3Sx-Q0pXVxU9GIV-S4Ac7FwOCE7L6jUzl46yvlHO6sypiqhNtkU239OBscK2XmjJWb_aqyfj3HfaX3Rd1YbbMtnx5NDNscSqYqhCpiyR0KxkYzF_5Bb_Llj_NScqgSviYvJ-USvrl_z8jvL59_XXyrr39-vbo4v65NS9tcC90iiB6AqgYEHXoziBFFPw0NipFirztGtYBu0GoEVEINeuK0Y0z3ppsEPyNXC3cMai230W5U3MugrLz7CHElVczWOJTAB942YmRq6JuJM83aSU2D6ChOk4a2sD4trO2sNzga9Dkq9wT6tOLtjVyFnaQMCoXxQnh_T4jhz4wpy41NBp1THsOcJGdAG4C2bYr13eNm_7o8bK4Y-sVQRp9SxEkam8ukw6G3dZKCPByJXI5EliORd0cib0uU_Rd9oD8b4ksoFbNfYZTrMEdflvdc6i_i9NH6 |
| CitedBy_id | crossref_primary_10_1016_j_smrv_2025_102123 crossref_primary_10_1007_s10495_025_02168_z crossref_primary_10_1007_s11033_025_10713_x crossref_primary_10_1016_j_intimp_2025_115078 |
| Cites_doi | 10.1016/j.cell.2012.02.035 10.1111/jpi.12503 10.1038/nature08780 10.1007/s00018-022-04628-0 10.1038/s41577-021-00524-z 10.1016/j.ebiom.2019.02.055 10.1111/jpi.12137 10.1371/journal.ppat.1011406 10.1038/s41418-022-01094-w 10.1038/s41580-020-0244-x 10.1016/S0140-6736(22)01439-8 10.2119/molmed.2011.00423 10.1038/nri3921 10.1016/j.cell.2013.04.046 10.1038/s41586-023-06373-1 10.1146/annurev-physiol-020518-114320 10.1038/nri.2017.36 10.1164/rccm.202201-0157OC 10.1146/annurev-pathol-052016-100247 10.1007/s00109-020-01886-y 10.1038/s12276-022-00889-8 10.1097/01.CCM.0000145947.19077.25 10.1016/j.freeradbiomed.2022.12.081 10.1073/pnas.1717190115 10.1080/15548627.2015.1052208 10.1164/rccm.201504-0781OC 10.1002/jmv.29076 10.1016/j.labinv.2023.100266 10.1186/s12888-020-02847-y 10.1016/j.arr.2022.101635 10.1056/NEJMoa022139 10.1001/jama.2016.0287 10.1038/cddis.2014.277 10.1038/cdd.2017.58 10.1016/S0140-6736(19)32989-7 10.1038/nature14156 10.1111/jpi.12520 10.1016/j.intimp.2022.108782 10.1016/j.ecoenv.2023.115777 10.1038/s41418-020-00732-5 10.3389/fimmu.2021.668002 10.1016/j.redox.2020.101777 10.1038/s41392-022-01046-3 10.1002/ctm2.1334 10.1111/jpi.12360 10.1016/S0140-6736(22)01485-4 10.1111/jpi.12855 10.1038/s12276-022-00847-4 10.1038/nature14191 10.1038/s41419-020-03239-6 10.1038/s41467-021-21984-w 10.1007/s00395-020-00832-w 10.1183/13993003.00786-2018 10.1001/jama.2016.0289 10.1038/s41419-021-03961-9 10.1111/jpi.12322 10.1186/s12943-020-01247-w 10.1038/s43018-022-00468-w 10.1111/jpi.12199 10.1016/j.bja.2021.10.039 10.1038/nrm.2016.149 10.1186/s13045-022-01392-3 10.4049/jimmunol.1701492 10.1182/blood.2020009063 10.1016/j.freeradbiomed.2021.01.045 10.1016/S0140-6736(88)90811-2 10.1111/jpi.12525 10.1038/s41581-022-00658-w 10.1186/s13054-019-2482-x 10.1165/rcmb.2009-0210ST 10.1038/s41577-022-00760-x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2025 2025. The Author(s). The Author(s) 2025 2025 |
| Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: The Author(s) 2025 2025 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
| DOI | 10.1186/s10020-025-01228-z |
| DatabaseName | Springer Nature Link OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ, Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1528-3658 |
| EndPage | 15 |
| ExternalDocumentID | oai_doaj_org_article_0393645d2a984f32b26faf9571effb06 PMC12057123 40335920 10_1186_s10020_025_01228_z |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: National Natural Science Foundation of China grantid: 82241041; 82241041; 82241041; 82241041; 82241041; 82241041; 82241041; 82241041; 82241041 funderid: https://doi.org/10.13039/501100001809 – fundername: National Natural Science Foundation of China grantid: 82241041 |
| GroupedDBID | --- -ET 0R~ 123 29M 2WC 36B 5RE 5VS 7X7 8FI 8FJ AAFWJ AAJSJ AASML ABUWG ACGFO ACMJI ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AIAGR ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HH5 HMCUK HYE IAO IH2 IHR ISR ITC KQ8 LGEZI LOTEE NADUK NXXTH OK1 OVT P2P PHGZM PHGZT PIMPY PUEGO RBZ RNS ROL RPM RSV SDH SJN SOJ SV3 TR2 UKHRP WOQ AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c616t-5b6e058001a405198c95de58f94e5d1e8b721b5079bad0ea5a9bf31722b8c7f53 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 5 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001484093700003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1528-3658 1076-1551 |
| IngestDate | Fri Oct 03 12:50:45 EDT 2025 Tue Nov 04 02:04:21 EST 2025 Fri Sep 05 17:14:28 EDT 2025 Sun May 11 01:40:59 EDT 2025 Sat Nov 29 07:58:05 EST 2025 Tue Nov 18 22:14:48 EST 2025 Sat Sep 06 07:22:13 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Sepsis Melatonin mtDNA-STING Necroptosis ALI |
| Language | English |
| License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c616t-5b6e058001a405198c95de58f94e5d1e8b721b5079bad0ea5a9bf31722b8c7f53 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://link.springer.com/10.1186/s10020-025-01228-z |
| PMID | 40335920 |
| PQID | 3201400664 |
| PQPubID | 23479 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0393645d2a984f32b26faf9571effb06 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12057123 proquest_miscellaneous_3201400664 pubmed_primary_40335920 crossref_citationtrail_10_1186_s10020_025_01228_z crossref_primary_10_1186_s10020_025_01228_z springer_journals_10_1186_s10020_025_01228_z |
| PublicationCentury | 2000 |
| PublicationDate | 2025-05-07 |
| PublicationDateYYYYMMDD | 2025-05-07 |
| PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-07 day: 07 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Molecular medicine (Cambridge, Mass.) |
| PublicationTitleAbbrev | Mol Med |
| PublicationTitleAlternate | Mol Med |
| PublicationYear | 2025 |
| Publisher | BioMed Central BMC |
| Publisher_xml | – name: BioMed Central – name: BMC |
| References | M Alsabani (1228_CR10) 2022; 128 KE Rudd (1228_CR4) 2020; 395 Q Liu (1228_CR50) 2021; 12 X Wang (1228_CR22) 2020; 115 X Yu (1228_CR55) 2020; 98 C Fleischmann (1228_CR1) 2016; 193 B Marcos-Ramiro (1228_CR5) 2014; 112 L Sagrillo-Fagundes (1228_CR51) 2018; 65 X Tong (1228_CR14) 2022; 15 Y Zhang (1228_CR57) 2016; 60 K Mao (1228_CR58) 2021; 12 Y Wang (1228_CR73) 2020; 19 S Marchi (1228_CR60) 2023; 23 X Zhang (1228_CR26) 2023; 13 X Zhang (1228_CR69) 2020; 11 M Brault (1228_CR76) 2018; 200 Y Qiang (1228_CR68) 2023; 269 M Shankar-Hari (1228_CR3) 2016; 315 Y Zhang (1228_CR52) 2022; 78 LDJ Bos (1228_CR44) 2022; 400 J Nunnari (1228_CR59) 2012; 148 M Pasparakis (1228_CR13) 2015; 517 CK Sun (1228_CR33) 2015; 58 D Chen (1228_CR67) 2018; 115 M Singer (1228_CR2) 2016; 315 J Cipolla-Neto (1228_CR27) 2014; 56 1228_CR42 JE Sevransky (1228_CR7) 2004; 32 A Maeda (1228_CR21) 2014; 5 M Sauler (1228_CR17) 2019; 81 KP Hopfner (1228_CR70) 2020; 21 EA Gorman (1228_CR45) 2022; 400 Y Yao (1228_CR30) 2023; 195 B Kolbrink (1228_CR48) 2023; 19 J Liu (1228_CR65) 2021; 28 K Yuge (1228_CR28) 2020; 20 H Zhou (1228_CR32) 2018; 65 D Rojas-Rivera (1228_CR75) 2017; 24 JY Kang (1228_CR35) 2022; 109 H Pi (1228_CR31) 2015; 11 ME Bowdish (1228_CR8) 2023; 207 R Hardeland (1228_CR54) 2018; 65 L Tumburu (1228_CR63) 2021; 137 N Samson (1228_CR74) 2022; 3 GS Martin (1228_CR41) 2003; 348 Z Wang (1228_CR53) 2023; 74 Q Zhang (1228_CR61) 2010; 464 W Gao (1228_CR12) 2022; 7 MGS Shashaty (1228_CR19) 2019; 23 Q Hu (1228_CR25) 2019; 41 L Galluzzi (1228_CR16) 2017; 12 A Linkermann (1228_CR15) 2012; 18 P Gao (1228_CR23) 2013; 153 H Zhu (1228_CR66) 2021; 38 L Ning (1228_CR9) 2022; 79 G Matute-Bello (1228_CR34) 2011; 44 RJ Reiter (1228_CR29) 2016; 61 HC Lane (1228_CR6) 1988; 2 R Weinlich (1228_CR47) 2017; 18 HH Yang (1228_CR49) 2022; 54 S Hao (1228_CR18) 2023; 95 L Zheng (1228_CR56) 2023; 103 GN Barber (1228_CR24) 2015; 15 MF Gulen (1228_CR72) 2023; 620 L Hou (1228_CR11) 2021; 165 1228_CR62 AP West (1228_CR20) 2015; 520 E Ju (1228_CR46) 2022; 54 E Vringer (1228_CR64) 2023; 30 A Decout (1228_CR71) 2021; 21 T van der Poll (1228_CR40) 2017; 17 C Huo (1228_CR43) 2023; 19 |
| References_xml | – volume: 148 start-page: 1145 issue: 6 year: 2012 ident: 1228_CR59 publication-title: Cell doi: 10.1016/j.cell.2012.02.035 – volume: 65 start-page: e12503 issue: 3 year: 2018 ident: 1228_CR32 publication-title: J Pineal Res doi: 10.1111/jpi.12503 – volume: 464 start-page: 104 issue: 7285 year: 2010 ident: 1228_CR61 publication-title: Nature doi: 10.1038/nature08780 – volume: 79 start-page: 610 issue: 12 year: 2022 ident: 1228_CR9 publication-title: Cell Mol Life Sci doi: 10.1007/s00018-022-04628-0 – volume: 112 start-page: 1088 issue: 6 year: 2014 ident: 1228_CR5 publication-title: Thromb Haemost – volume: 21 start-page: 548 issue: 9 year: 2021 ident: 1228_CR71 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00524-z – volume: 41 start-page: 497 year: 2019 ident: 1228_CR25 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.02.055 – volume: 56 start-page: 371 issue: 4 year: 2014 ident: 1228_CR27 publication-title: J Pineal Res doi: 10.1111/jpi.12137 – volume: 19 start-page: e1011406 issue: 5 year: 2023 ident: 1228_CR43 publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1011406 – volume: 30 start-page: 304 issue: 2 year: 2023 ident: 1228_CR64 publication-title: Cell Death Differ doi: 10.1038/s41418-022-01094-w – volume: 21 start-page: 501 issue: 9 year: 2020 ident: 1228_CR70 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/s41580-020-0244-x – volume: 400 start-page: 1157 issue: 10358 year: 2022 ident: 1228_CR45 publication-title: Lancet doi: 10.1016/S0140-6736(22)01439-8 – volume: 18 start-page: 577 issue: 1 year: 2012 ident: 1228_CR15 publication-title: Mol Med doi: 10.2119/molmed.2011.00423 – volume: 15 start-page: 760 issue: 12 year: 2015 ident: 1228_CR24 publication-title: Nat Rev Immunol doi: 10.1038/nri3921 – volume: 153 start-page: 1094 issue: 5 year: 2013 ident: 1228_CR23 publication-title: Cell doi: 10.1016/j.cell.2013.04.046 – volume: 620 start-page: 374 issue: 7973 year: 2023 ident: 1228_CR72 publication-title: Nature doi: 10.1038/s41586-023-06373-1 – volume: 81 start-page: 375 year: 2019 ident: 1228_CR17 publication-title: Annu Rev Physiol doi: 10.1146/annurev-physiol-020518-114320 – volume: 17 start-page: 407 issue: 7 year: 2017 ident: 1228_CR40 publication-title: Nat Rev Immunol doi: 10.1038/nri.2017.36 – volume: 207 start-page: 261 issue: 3 year: 2023 ident: 1228_CR8 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202201-0157OC – volume: 12 start-page: 103 year: 2017 ident: 1228_CR16 publication-title: Annu Rev Pathol doi: 10.1146/annurev-pathol-052016-100247 – volume: 98 start-page: 569 issue: 4 year: 2020 ident: 1228_CR55 publication-title: J Mol Med (Berl) doi: 10.1007/s00109-020-01886-y – volume: 54 start-page: 2077 issue: 11 year: 2022 ident: 1228_CR49 publication-title: Exp Mol Med doi: 10.1038/s12276-022-00889-8 – volume: 32 start-page: S548 issue: 11 Suppl year: 2004 ident: 1228_CR7 publication-title: Crit Care Med doi: 10.1097/01.CCM.0000145947.19077.25 – volume: 195 start-page: 13 year: 2023 ident: 1228_CR30 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2022.12.081 – volume: 115 start-page: 3930 issue: 15 year: 2018 ident: 1228_CR67 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1717190115 – volume: 11 start-page: 1037 issue: 7 year: 2015 ident: 1228_CR31 publication-title: Autophagy doi: 10.1080/15548627.2015.1052208 – volume: 193 start-page: 259 issue: 3 year: 2016 ident: 1228_CR1 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201504-0781OC – volume: 95 start-page: e29076 issue: 9 year: 2023 ident: 1228_CR18 publication-title: J Med Virol doi: 10.1002/jmv.29076 – volume: 103 start-page: 100266 issue: 12 year: 2023 ident: 1228_CR56 publication-title: Lab Invest doi: 10.1016/j.labinv.2023.100266 – volume: 20 start-page: 445 issue: 1 year: 2020 ident: 1228_CR28 publication-title: BMC Psychiatry doi: 10.1186/s12888-020-02847-y – volume: 78 start-page: 101635 year: 2022 ident: 1228_CR52 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2022.101635 – volume: 348 start-page: 1546 issue: 16 year: 2003 ident: 1228_CR41 publication-title: N Engl J Med doi: 10.1056/NEJMoa022139 – volume: 315 start-page: 801 issue: 8 year: 2016 ident: 1228_CR2 publication-title: JAMA doi: 10.1001/jama.2016.0287 – volume: 5 start-page: e1312 issue: 7 year: 2014 ident: 1228_CR21 publication-title: Cell Death Dis doi: 10.1038/cddis.2014.277 – volume: 24 start-page: 1100 issue: 6 year: 2017 ident: 1228_CR75 publication-title: Cell Death Differ doi: 10.1038/cdd.2017.58 – volume: 395 start-page: 200 issue: 10219 year: 2020 ident: 1228_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(19)32989-7 – volume: 520 start-page: 553 issue: 7548 year: 2015 ident: 1228_CR20 publication-title: Nature doi: 10.1038/nature14156 – volume: 65 start-page: e12520 issue: 4 year: 2018 ident: 1228_CR51 publication-title: J Pineal Res doi: 10.1111/jpi.12520 – volume: 109 start-page: 108782 year: 2022 ident: 1228_CR35 publication-title: Int Immunopharmacol doi: 10.1016/j.intimp.2022.108782 – volume: 269 start-page: 115777 year: 2023 ident: 1228_CR68 publication-title: Ecotoxicol Environ Saf doi: 10.1016/j.ecoenv.2023.115777 – volume: 28 start-page: 2045 issue: 7 year: 2021 ident: 1228_CR65 publication-title: Cell Death Differ doi: 10.1038/s41418-020-00732-5 – volume: 12 start-page: 668002 year: 2021 ident: 1228_CR58 publication-title: Front Immunol doi: 10.3389/fimmu.2021.668002 – volume: 38 start-page: 101777 year: 2021 ident: 1228_CR66 publication-title: Redox Biol doi: 10.1016/j.redox.2020.101777 – volume: 7 start-page: 196 issue: 1 year: 2022 ident: 1228_CR12 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-022-01046-3 – volume: 13 start-page: e1334 issue: 7 year: 2023 ident: 1228_CR26 publication-title: Clin Transl Med doi: 10.1002/ctm2.1334 – volume: 61 start-page: 253 issue: 3 year: 2016 ident: 1228_CR29 publication-title: J Pineal Res doi: 10.1111/jpi.12360 – volume: 400 start-page: 1145 issue: 10358 year: 2022 ident: 1228_CR44 publication-title: Lancet doi: 10.1016/S0140-6736(22)01485-4 – volume: 74 start-page: e12855 issue: 3 year: 2023 ident: 1228_CR53 publication-title: J Pineal Res doi: 10.1111/jpi.12855 – volume: 54 start-page: 1401 issue: 9 year: 2022 ident: 1228_CR46 publication-title: Exp Mol Med doi: 10.1038/s12276-022-00847-4 – volume: 517 start-page: 311 issue: 7534 year: 2015 ident: 1228_CR13 publication-title: Nature doi: 10.1038/nature14191 – volume: 11 start-page: 1050 issue: 12 year: 2020 ident: 1228_CR69 publication-title: Cell Death Dis doi: 10.1038/s41419-020-03239-6 – ident: 1228_CR62 doi: 10.1038/s41467-021-21984-w – volume: 115 start-page: 66 issue: 6 year: 2020 ident: 1228_CR22 publication-title: Basic Res Cardiol doi: 10.1007/s00395-020-00832-w – ident: 1228_CR42 doi: 10.1183/13993003.00786-2018 – volume: 315 start-page: 775 issue: 8 year: 2016 ident: 1228_CR3 publication-title: JAMA doi: 10.1001/jama.2016.0289 – volume: 12 start-page: 673 issue: 7 year: 2021 ident: 1228_CR50 publication-title: Cell Death Dis doi: 10.1038/s41419-021-03961-9 – volume: 60 start-page: 405 issue: 4 year: 2016 ident: 1228_CR57 publication-title: J Pineal Res doi: 10.1111/jpi.12322 – volume: 19 start-page: 136 issue: 1 year: 2020 ident: 1228_CR73 publication-title: Mol Cancer doi: 10.1186/s12943-020-01247-w – volume: 3 start-page: 1452 issue: 12 year: 2022 ident: 1228_CR74 publication-title: Nat Cancer doi: 10.1038/s43018-022-00468-w – volume: 58 start-page: 137 issue: 2 year: 2015 ident: 1228_CR33 publication-title: J Pineal Res doi: 10.1111/jpi.12199 – volume: 128 start-page: 283 issue: 2 year: 2022 ident: 1228_CR10 publication-title: Br J Anaesth doi: 10.1016/j.bja.2021.10.039 – volume: 18 start-page: 127 issue: 2 year: 2017 ident: 1228_CR47 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm.2016.149 – volume: 15 start-page: 174 issue: 1 year: 2022 ident: 1228_CR14 publication-title: J Hematol Oncol doi: 10.1186/s13045-022-01392-3 – volume: 200 start-page: 2748 issue: 8 year: 2018 ident: 1228_CR76 publication-title: J Immunol doi: 10.4049/jimmunol.1701492 – volume: 137 start-page: 3116 issue: 22 year: 2021 ident: 1228_CR63 publication-title: Blood doi: 10.1182/blood.2020009063 – volume: 165 start-page: 219 year: 2021 ident: 1228_CR11 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2021.01.045 – volume: 2 start-page: 1218 issue: 8622 year: 1988 ident: 1228_CR6 publication-title: Lancet doi: 10.1016/S0140-6736(88)90811-2 – volume: 65 start-page: e12525 issue: 4 year: 2018 ident: 1228_CR54 publication-title: J Pineal Res doi: 10.1111/jpi.12525 – volume: 19 start-page: 300 issue: 5 year: 2023 ident: 1228_CR48 publication-title: Nat Rev Nephrol doi: 10.1038/s41581-022-00658-w – volume: 23 start-page: 235 issue: 1 year: 2019 ident: 1228_CR19 publication-title: Crit Care doi: 10.1186/s13054-019-2482-x – volume: 44 start-page: 725 issue: 5 year: 2011 ident: 1228_CR34 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2009-0210ST – volume: 23 start-page: 159 issue: 3 year: 2023 ident: 1228_CR60 publication-title: Nat Rev Immunol doi: 10.1038/s41577-022-00760-x |
| SSID | ssj0021545 |
| Score | 2.4723287 |
| Snippet | Background
Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and... Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high morbidity and mortality... Abstract Background Sepsis is a life-threatening condition that often leads to severe complications, including acute lung injury (ALI), which carries high... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 176 |
| SubjectTerms | Acute Lung Injury - blood Acute Lung Injury - drug therapy Acute Lung Injury - etiology Acute Lung Injury - metabolism Acute Lung Injury - pathology ALI Animals Biomarkers Biomedical and Life Sciences Biomedicine Cytokines - blood Cytokines - metabolism Disease Models, Animal DNA, Mitochondrial - blood DNA, Mitochondrial - genetics DNA, Mitochondrial - metabolism Male Melatonin Melatonin - pharmacology Melatonin - therapeutic use Mice Mice, Inbred C57BL Molecular Medicine mtDNA-STING Necroptosis Necroptosis - drug effects Sepsis Sepsis - complications Sepsis - drug therapy Signal Transduction - drug effects |
| SummonAdditionalLinks | – databaseName: DOAJ, Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nj9QgFCdmo4kX47fdXQ0m3pQ40ELhuH5svDjxoMneCFDI1qydzbQzye5f73u0nThq1otJD6RAC7z3yu8VeD9CXukyAS5QgWkeHKt0w5mvjGDJxSoaDVqUUiabqJdLfXZmvvxC9YV7wsbwwOPAvcWzo6qSjXBGV6kUXqjkkpE1jyn5Mdg2oJ7ZmZpcLQQG8xEZrfCgHLpJSN2KS0maXe9NQzla_98g5p87JX9bLs2z0Ol9cm-Cj_RkbPYDcit2D8mdkVDy6hHZfsa9bfiHlSJHyrZFJEn7eNm3PQPvG-TYUBc2Q6QXYOW07b7DmFJ_Banz1re4B5p2EWm9hhXUofAEusborpgR2nXIbF-Q_jF8WJ5QZFyBafAx-Xb68ev7T2xiVmBBcTUw6VVcSMCK3FWI4XQwsolSJ1NF2fCoPTiGHqCi8a5ZRCed8QmQhhBehzrJ8gk56FZdfEZoncCh0ipGCebWKONgvi-bZBxAES6UKwifB9qGKew4sl9c2Ox-aGVH4VgQjs3CsdcFeb2rczkG3bix9DuU364kBszON0CN7KRG9l9qVJCXs_QtGBiumrgurja9LQU6oYDMqoI8HbVh96pqUZbSiEVB9J6e7LVlP6drz3MQby4AKQNsKMibWaXs9Pnob-js4f_o7BG5K7ItwFUfk4NhvYnPye2wHdp-_SJb0k9-0yI2 priority: 102 providerName: Directory of Open Access Journals |
| Title | Melatonin alleviates sepsis-induced acute lung injury by inhibiting necroptosis via reducing circulating mtDNA release |
| URI | https://link.springer.com/article/10.1186/s10020-025-01228-z https://www.ncbi.nlm.nih.gov/pubmed/40335920 https://www.proquest.com/docview/3201400664 https://pubmed.ncbi.nlm.nih.gov/PMC12057123 https://doaj.org/article/0393645d2a984f32b26faf9571effb06 |
| Volume | 31 |
| WOSCitedRecordID | wos001484093700003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1528-3658 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021545 issn: 1528-3658 databaseCode: RBZ dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1528-3658 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021545 issn: 1528-3658 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1528-3658 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021545 issn: 1528-3658 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1528-3658 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021545 issn: 1528-3658 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1528-3658 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021545 issn: 1528-3658 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1528-3658 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021545 issn: 1528-3658 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBZN0kJfeh_usajQt9awli1ZekzahPYhy5IebJ-EZEuJS-oNtnch-fWdke2FbUOgBWNsS7JlaUb6Rsd8hLyVqQdcIIpYJoWJM1kmsc0Ui71xmVMSpMj7QDaRz2ZysVDzYVNYO652H6ckQ0sd1FoK3OyGpg7Sr-J0kIyvdsgedHcS1fHky_eNmYWgYNwec226rS4oeOq_Dl7-vUryj6nS0AMd3f-_vD8g9wbESfd7EXlIbrn6EbnTc1BePibrY1wOh4OyFGlV1hWCT9q6i7ZqYzDYoepLaopV5-g5NAy0qn9CNVB7CVdnla1w2TStHTKBdUtIQ-ENtEGHsBhQVE0RCMLg-lf3cbZPkaQFes4n5NvR4dcPn-KBjCEuRCK6mFvhphzgZWIyhH2yULx0XHqVOV4mTlqwJS2gS2VNOXWGG2U9gBPGrCxyz9OnZLde1u45obkHG0wK5zhoaCmUAYiQll4ZQC8JEyYiyVg_uhg8lSNhxrkOFosUui9PDeWpQ3nqq4i826S56P103Bj7AKt9ExN9bIcHy-ZUDyqrcdeyyHjJjJKZT5llwhuveJ447-1UROTNKDQadBInWkztlqtWpwztVgBzWUSe9UK0-VQ2TVOu2DQicku8tvKyHVJXZ8Hvd8IAXAPSiMj7Ucr00OK0N_zsi3-L_pLcZUFQ4chfkd2uWbnX5Hax7qq2mZCdfJGHs5yQvYPD2fxkEsYx4G7--Xj-YxKU8TdDMi1H |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaggODC-xGeRuIGkRIn9trH8qiKaFcICurNsh2bBpVslWRXan89M06y0kJVCaQcrNhOHHvG_iYez0fIK1kEwAXCpTJ3Ji1llae2VCwNxpdeSZCiECLZxGw-l4eH6vN4KKybvN2nLck4U0e1lgIPu6Gpg_SruB0k07PL5EoJKxY68n35-n1tZiEomI7HnFtvYwmKkfrPg5d_e0n-sVUaV6CdW__X9tvk5og46fYgInfIJd_cJdcGDsrTe2S1j-5w-FOWIq3KqkbwSTt_0tVdCgY7DH1FjVv2nh7DxEDr5icMA7WnkDqqbY1u07TxyATWL6AOhSfQFgPCYoarWxcJwiD9q38_36ZI0gIr533ybefDwbvddCRjSJ3IRZ9yK3zGAV7mpkTYJ53ilecyqNLzKvfSgi1pAV0qa6rMG26UDQBOGLPSzQIvHpCtZtH4R4TOAthgUnjPQUMroQxAhKIKygB6yZkwCcmn8dFujFSOhBnHOlosUuihPzX0p479qc8S8npd52SI03Fh6bc47OuSGGM73li0P_SoshpPLYuSV8woWYaCWSaCCYrPch-CzURCXk5Co0EncaPFNH6x7HTB0G4FMFcm5OEgROtXlVlRcMWyhMgN8dpoy2ZOUx_FuN85A3ANSCMhbyYp0-OM013wsY__rfgLcn33YH9P732cf3pCbrAotHDNnpKtvl36Z-SqW_V11z6Pavcbi1UqGw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwELagHOKF-winkXiDqIkTO_ZjoaxAwKoSh_pm2YlNg0p2lWRXan89M06yYqGqhJDyEMV2Dueb-JvYMx8hL2TmgReIMpZpaeJcVmlsc8Vib1zulAQUeR_EJor5XB4eqoPfovjDavdpSnKIacAsTU2_u6z8YOJSYOAbuj0oxYpTQzI-vUgu5SgahP76528blwsJwhQqc2a7reEoZO0_i2r-vWLyj2nTMBrNbvz_c9wk10cmSvcG6NwiF1xzm1wZtClP7pD1J1wmhz9rKcqtrGskpbRzy67uYnDkARIVNeWqd_QYPhi0bn7A66H2BPaOalvjcmraOFQI6xfQhsIZaIuJYrGgrNsyCIfB_s9-f75HUbwFRtS75Ovs7Zc37-JRpCEuRSr6mFvhEg60MzU50kFZKl45Lr3KHa9SJy34mBZYp7KmSpzhRlkPpIUxK8vC8-we2WkWjXtAaOHBN5PCOQ6WWwllgDpklVcGWE3KhIlIOr0rXY4ZzFFI41gHT0YKPfSnhv7UoT_1aURebtosh_wd59Z-jRDY1MTc2-HAov2uR1PWGM0scl4xo2TuM2aZ8MYrXqTOe5uIiDyfAKTBVnECxjRusep0xtCfBZKXR-T-AKjNpfIky7hiSUTkFtS27mW7pKmPQj7wlAHpBgYSkVcT4vT4JerOediH_1b9Gbl6sD_TH9_PPzwi11jALGzFY7LTtyv3hFwu133dtU-DBf4COYky_w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Melatonin+alleviates+sepsis-induced+acute+lung+injury+by+inhibiting+necroptosis+via+reducing+circulating+mtDNA+release&rft.jtitle=Molecular+medicine+%28Cambridge%2C+Mass.%29&rft.au=Peng%2C+Yuce&rft.au=Xu%2C+Jia&rft.au=Wei%2C+Lingyu&rft.au=Luo%2C+Minghao&rft.date=2025-05-07&rft.issn=1528-3658&rft.eissn=1528-3658&rft.volume=31&rft.issue=1&rft_id=info:doi/10.1186%2Fs10020-025-01228-z&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s10020_025_01228_z |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-3658&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-3658&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-3658&client=summon |